Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients
Abstract Background Iodinated contrast media may contribute to acute kidney injury. However, several recent works suggest that this toxicity is minimal in the clinical setting. Recently, urinary G1 cell-cycle arrest proteins tissue inhibitor of metalloproteinase 2 (TIMP-2) and insulin like growth fa...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-018-1091-2 |
id |
doaj-7f202586186d4b069bf7ac8b5085ca69 |
---|---|
record_format |
Article |
spelling |
doaj-7f202586186d4b069bf7ac8b5085ca692020-11-25T01:16:21ZengBMCBMC Nephrology1471-23692018-11-011911710.1186/s12882-018-1091-2Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patientsEmmanuelle Rouve0Karim Lakhal1Charlotte Salmon Gandonnière2Youenn Jouan3Laetitia Bodet-Contentin4Stephan Ehrmann5Medecine Intensive Reanimation, CIC 1415, CRICS-Triggersep network, CHRU de ToursReanimation chirurgicale polyvalente, service d’anesthesie-reanimation, Hôpital Laënnec, centre hospitalier universitaireMedecine Intensive Reanimation, CIC 1415, CRICS-Triggersep network, CHRU de ToursMedecine Intensive Reanimation, CIC 1415, CRICS-Triggersep network, CHRU de ToursMedecine Intensive Reanimation, CIC 1415, CRICS-Triggersep network, CHRU de ToursMedecine Intensive Reanimation, CIC 1415, CRICS-Triggersep network, CHRU de ToursAbstract Background Iodinated contrast media may contribute to acute kidney injury. However, several recent works suggest that this toxicity is minimal in the clinical setting. Recently, urinary G1 cell-cycle arrest proteins tissue inhibitor of metalloproteinase 2 (TIMP-2) and insulin like growth factor binding protein 7 (IGFBP-7) were identified as highly sensitive and specific biomarkers for early detection of kidney aggression. The impact of contrast administration on those biomarkers has not been specifically evaluated but could provide clues about the toxicity of contrast media. This study aimed at measuring changes in TIMP-2 and IGFBP-7 urinary concentrations before and after a contrast-enhanced computed tomography in critically ill patients. Methods 77 patients were included in a prospective observational cohort study. Urinary [TIMP -2]·[IGFBP-7] was measured before, 6 and 24 h after contrast infusion. Urine output and serum creatinine were followed 3 days. Results Median [TIMP-2]·[IGFBP-7] was 0.06 [interquartile range 0.04;0.26], 0.07 [0.03;0.34] and 0.10 [0.04;0.37] (ng/mL)2/1000 respectively before, 6 and 24 h after contrast infusion. Individual changes from baseline were − 0.01 [− 0.11;0.11] and 0.00 [− 0.10;0.09] (ng/ml)2/1000 at 6 and 24 h. These changes were not higher among the patients increasing their Kidney Disease Improving Global Outcome (KDIGO) classification within 3 days after contrast infusion (n = 14 [18%] based on creatinine criterion only, n = 42 [55%] based on creatinine and urine output). Conclusions Changes in [TIMP-2]·[IGFBP-7] urinary concentration after contrast-enhanced computed tomography were insignificant, suggesting minimal kidney aggression by modern iodinated contrast media.http://link.springer.com/article/10.1186/s12882-018-1091-2Acute kidney injuryIodinated contrast mediaBiomarkersTIMP-2IGFBP-7Iohexol |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Emmanuelle Rouve Karim Lakhal Charlotte Salmon Gandonnière Youenn Jouan Laetitia Bodet-Contentin Stephan Ehrmann |
spellingShingle |
Emmanuelle Rouve Karim Lakhal Charlotte Salmon Gandonnière Youenn Jouan Laetitia Bodet-Contentin Stephan Ehrmann Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients BMC Nephrology Acute kidney injury Iodinated contrast media Biomarkers TIMP-2 IGFBP-7 Iohexol |
author_facet |
Emmanuelle Rouve Karim Lakhal Charlotte Salmon Gandonnière Youenn Jouan Laetitia Bodet-Contentin Stephan Ehrmann |
author_sort |
Emmanuelle Rouve |
title |
Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients |
title_short |
Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients |
title_full |
Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients |
title_fullStr |
Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients |
title_full_unstemmed |
Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients |
title_sort |
lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients |
publisher |
BMC |
series |
BMC Nephrology |
issn |
1471-2369 |
publishDate |
2018-11-01 |
description |
Abstract Background Iodinated contrast media may contribute to acute kidney injury. However, several recent works suggest that this toxicity is minimal in the clinical setting. Recently, urinary G1 cell-cycle arrest proteins tissue inhibitor of metalloproteinase 2 (TIMP-2) and insulin like growth factor binding protein 7 (IGFBP-7) were identified as highly sensitive and specific biomarkers for early detection of kidney aggression. The impact of contrast administration on those biomarkers has not been specifically evaluated but could provide clues about the toxicity of contrast media. This study aimed at measuring changes in TIMP-2 and IGFBP-7 urinary concentrations before and after a contrast-enhanced computed tomography in critically ill patients. Methods 77 patients were included in a prospective observational cohort study. Urinary [TIMP -2]·[IGFBP-7] was measured before, 6 and 24 h after contrast infusion. Urine output and serum creatinine were followed 3 days. Results Median [TIMP-2]·[IGFBP-7] was 0.06 [interquartile range 0.04;0.26], 0.07 [0.03;0.34] and 0.10 [0.04;0.37] (ng/mL)2/1000 respectively before, 6 and 24 h after contrast infusion. Individual changes from baseline were − 0.01 [− 0.11;0.11] and 0.00 [− 0.10;0.09] (ng/ml)2/1000 at 6 and 24 h. These changes were not higher among the patients increasing their Kidney Disease Improving Global Outcome (KDIGO) classification within 3 days after contrast infusion (n = 14 [18%] based on creatinine criterion only, n = 42 [55%] based on creatinine and urine output). Conclusions Changes in [TIMP-2]·[IGFBP-7] urinary concentration after contrast-enhanced computed tomography were insignificant, suggesting minimal kidney aggression by modern iodinated contrast media. |
topic |
Acute kidney injury Iodinated contrast media Biomarkers TIMP-2 IGFBP-7 Iohexol |
url |
http://link.springer.com/article/10.1186/s12882-018-1091-2 |
work_keys_str_mv |
AT emmanuellerouve lackofimpactofiodinatedcontrastmediaonkidneycellcyclearrestbiomarkersincriticallyillpatients AT karimlakhal lackofimpactofiodinatedcontrastmediaonkidneycellcyclearrestbiomarkersincriticallyillpatients AT charlottesalmongandonniere lackofimpactofiodinatedcontrastmediaonkidneycellcyclearrestbiomarkersincriticallyillpatients AT youennjouan lackofimpactofiodinatedcontrastmediaonkidneycellcyclearrestbiomarkersincriticallyillpatients AT laetitiabodetcontentin lackofimpactofiodinatedcontrastmediaonkidneycellcyclearrestbiomarkersincriticallyillpatients AT stephanehrmann lackofimpactofiodinatedcontrastmediaonkidneycellcyclearrestbiomarkersincriticallyillpatients |
_version_ |
1725150073145262080 |